Ampersand Capital acquires Purna Pharmaceuticals
Wednesday, March 4, 2026 · first reported by Pharmaceutical Business review -
Ampersand Capital acquired Purna Pharmaceuticals in healthcare expansion. Transaction shows continued deployment in pharma/biotech sector consistent with firm's healthcare focus.
- Also named
- Purna Pharmaceuticals
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Clear Channel Outdoor Holdings, Inc. Agrees to be Acquired by Mubadala Capital, in Partnership with TWG Global, for $6.2 BillionPR Newswire
- CW Advisors Pushed Westward with $849M Rovin Capital Dealconnectmoney.com
- Cerity Partners to Merge With Investment Consultant VerusChief Investment Officer +3
- French private equity firm Antin to acquire Vigor Marine GroupNaval News +1
- Kingswood Capital Management Enters Into a Definitive Agreement to Acquire Coveris’ Paper Unit, Rebrands as Paragon Print and PackagingBusiness Wire
- KPS CAPITAL PARTNERS TO ACQUIRE THE WELLS COMPANIES, INC. | CorporateEQS News